Alexander, F., French, T.M., & Pollock, G.H. (1968), Psychosomatic Specificity.Chicago: University of Chicago Press.
2.
Ammon, G. (1979), Psychoanalysis and Psychosomatics.New York: Springer.
3.
Berkanovic, E. & Krochalk, P.C. (1977), Occupational mobility and health. In:Epidemiologic Studies in Psychosomatic Medicine, vol. 9, Advances in Psychosomatic Medicine, ed. S. Kasl & F. Reichsman. Basel, Switzerland: S. Karger AG, pp. 132–139.
4.
Berson, S.A. & Yalow, R.S. (1971), Gastrin in duodenal ulcer.New England J. Med., 284: 445.
5.
Carp, F.M. (1977), Retirement and physical health. In:Epidemiologic Studies in Psychosomatic Medicine, vol. 9, Advances in Psychosomatic Medicine, ed. S. Kasl & F. Reichsman. Basel, Switzerland: S. Karger AG, pp. 140–159.
6.
Carroll, B.J. (1978), Neuroendocrine function in psychiatric disorders. In:Psycho-pharmacology: A Generation of Progress, ed. M.A. Lipton, A. DiMascio, & K.F. Killman. New York: Raven Press, pp. 487–497.
7.
Carroll, B.J.Curtis, G. C., & Mendels, J. (1976), Neuroendocrine regulation in depression: II, Discrimination of depressed from nondepressed patients.Arch. Gen. Psychiat., 33: 1051–1058.
8.
Carroll, B.J. & Mendels, J. (1976), Neuroendocrine regulation in affective disorders. In: Hormones, Behavior and Psychopathology, ed. E.J. Sachar. New York: Raven Press, pp. 193–224.
9.
Cremerius, J. (1957), Freuds Konzept über die Entstehung psychogener Körper-symptome.Psyche, 11: 125–139.
10.
Deutsch, F. (1959), On the Mysterious Leap from the Mind to the Body.New York: International Universities Press.
11.
Engel, G.L. (1954), Selection of clinical material in psychosomatic medicine: The need for a new physiology.Psychosom. Med., 16: 368.
12.
Engel, G.L. (1968), The psychoanalytic approach to psychosomatic medicine. In:Modem Psychoanalysis: New Directions and Perspectives, ed. J. Marmor. New York: Basic Books, pp. 251–273.
13.
Engel, G.L. (1977), The need for a new medical model: A challenge for biomedicine.Science, 196: 129–135.
14.
Gram, L., Reisby, N., & Ibsen, I. (1976), Plasma levels and anti-depressive effect of imipramine.Clin. Pharmacol. Ther., 19: 318–324.
15.
Harlow, H.F., Dodsworth, R.O., & Harlow, M.K. (1965), Total social isolation in monkeys.Proc. Natl. Acad. Sci. USA, 54: 90–97.
16.
Hinkle, L.E., Jr., (1974), The effect of exposure to culture change, social change, and changes in interpersonal relationships on health. In:Stressful Life Events: Their Nature and Effects, ed. B.S. Dohrenwend & B.P. Dohrenwend. New York: Wiley, pp. 9–44.
17.
Hollingshead, A.B. & Redlich, F.C (1958), Social Class and Mental Illness: A Community Study.New York: Wiley.
18.
Hughes, J. (1975), Search for the endogenous ligand of the opiate receptor.Neurosci. Res. Prog. Bull., 13: 55–57.
19.
Jenkins, CD. (1977), Epidemiological studies of the psychosomatic aspects of coronary heart disease: A review. In:Epidemiologic Studies in Psychosomatic Medicine, vol. 9, Advances in Psychosomatic Medicine, ed. S. Kasl & F. Reichsman. Basel, Switzerland: S. Karger AG, pp. 1–19.
Jenkins, CD. (1979b), Psychosocial modifiers of response to stress.J. Human Stress, 15: 3–15.
23.
Kasl, S. (1977), Contributions of social epidemiology to studies in psychosomatic medicine. In:Epidemiologic Studies in Psychosomatic Medicine, vol. 9, Advances in Psychosomatic Medicine, ed. S. Kasl & F. Reichsman. Basel, Switzerland: S. Karger AG, pp. 160–223.
24.
Kasl, S. & Cobb, S. (1970), Blood pressure changes in men undergoing job loss: A preliminary report.Psychosom. Med., 32: 19–38.
25.
Klein, D.F., Zitrin, CM. & Woerner, M. (1978), Anti-depressants, anxiety, panic and phobia. In:Psychopharmacology: A Generation of Progress, ed. M.A. Lipton, A. DiMascio, & K.F. Killman. New York: Raven Press, pp. 1401–1410.
26.
Klerman, G.L. (1975), Combining drugs and psychotherapy in the treatment of depression. In:Drugs in Combination with Other Therapy, ed. M. Greenblatt. New York: Grune & Stratton, pp. 67–82.
27.
Klerman, G.L. & Izen, J.E. (1977), The effects of bereavement and grief on physical health and general well-being. In:Epidemiologic Studies in Psychosomatic Medicine, vol. 9, Advances in Psychosomatic Medicine, ed. S. Kasl & F. Reichsman. Basel, Switzerland: S. Karger AG, pp. 63–104.
28.
Knapp, P.H. (1971), President's address: Revolution, relevance and psychosomatic medicine: Where the light is not.Psychosom. Med., 33: 363–374.
29.
Knapp, P.H. (1979), Emotions and bodily changes: A psychoanalytic reconsideration. Unpublished manuscript.
30.
Knapp, P.H. et al. (1970), The context of reported asthma during psychoanalysis.Psychosom. Med., 32: 167–188.
31.
Levine, J.D., Gordon, N.C., & Fields, H.L. (1978), The mechanisms of placebo analgesia.Lancet, 9: 654–655.
32.
Lipowski, Z.J. (1975), Physical illness, the patient and his environment: Psychosocial foundations of medicine. In:American Handbook of Psychiatry, Vol. 4, ed. M.F. Reiser. New York: Basic Books, pp. 3–42.
33.
Mahler, M., Pine, F., & Bergman, A. (1975), The Psychological Birth of the Human Infant.New York: Basic Books.
34.
Marty, P. & de M'Uzan, M. (1963), La pensée operatoire.Rev. Franç. Psychanai, 27: 345–356.
35.
Maseri, A. et al. (1979), Significance of spasm in the pathogenesis of ischemic heart disease.Amer. J. Cardiol, 44: 788–792.
36.
McDougall, J. (1974), The psycho-soma and the psychoanalytic process.Internal. Rev. Psycho-Anal, 1: 437–459.
37.
Mirsky, I. A. (1958), Physiologic, psychologic and social determinants in the etiology of duodenal ulcer.Amer. J. Dig. Dis., 3: 285–314.
38.
Mitscherlich, A. & de Boor, C. (1973), Verstehende psychosomatik: ein Stiefkind der Medizin.Psyche, 27: 1–20.
39.
Mora, G. (1975), Adolf Meyer. In:Comprehensive Textbook of Psychiatry, vol. I, ed. A. Freedman, H. Kaplan, B. Sadock. Baltimore: Williams & Wilkins, pp. 626–632.
40.
Mushatt, C. (1975), Mind, body, environment.Psychoanal. Quart., 44: 81–105.
41.
Mushatt, C. (1980), Loss, separation and psychosomatic illness: Reflections on the problem of psychoanalytic treatment of patients with physical illness. Unpublished manuscript.
42.
M'Uzan, M. de (1974), Analytical process and the notion of the past.Internat. Rev. Psycho-Anal., 1: 461–466.
43.
Myers, J. K. & Bean, L.L. (1968), A Decade Later: A Follow-Up of Social Class and Mental Illness.New York: Wiley.
44.
Nemiah, J.C., Freyberger, H., & Sifneos, P.E. (1976), Alexithymia: A view of the psychosomatic process. In:Modem Trends in Psychosomatic Medicine, Vol. 3, ed. O.W. Hill. London: Butterworths, pp. 430–439.
45.
Perel, J.M. et al. (1977), Clinical implications of imipramine plasma levels for depressive illness.Arch. Gen. Psychiat., 34: 197–204.
46.
Pollock, G.H. (1977), The ghost that will not go away: Specificity theory today.J. Amer. Acad. Psychoanal., 5: 421–430.
47.
Puig-Antich, J. (in preparation), Modern developments in the treatment of major depressive disorder in prepubertal school-age children.
48.
Puig-Antich, Chamber, W. et al. (1979), Cortisol hypersecretion in prepubertal depressive illness: A preliminary report.Psychoneuroendocrinology, 4: 191–197.
49.
Puig-Antich, Perel, J.M. et al. (1979), Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder.J. Amer. Acad. Child Psychiat., 18: 616–627.
50.
Reiser, M.F. (1975), Changing theoretical concepts in psychosomatic medicine. In:American Handbook of Psychiatry, Vol. 4, ed. M.F. Reiser. New York: Basic Books, pp. 477–500.
51.
Sachar, E.J. (1975a), Twenty-four-hour Cortisol secretory patterns in depressed and manic patients. In:Progress in Brain Research, Vol. 42, ed. W.H. Gispen et al. Amsterdam: Elsevier Scientific Publ. Co., pp. 81–91.
52.
Sachar, E.J. (1975b), Neuroendocrine abnormalities in depressive illness. In:Topics in Psychoneuroendocrinology, ed. E.J. Sachar. New York: Grune & Stratton, pp. 135–156.
53.
Sachar, E.J. et al. (1973), Disrupted 24 hour pattern of control secretion in psychotic depression.Arch. Gen. Psychiat., 28: 19–25.
54.
Schmale, A.H. (1972), Giving up as a final common pathway to changes in health. In:Psychosocial Aspects of Physical Illness, vol. 8, Advances in Psychosomatic Medicine, ed.S. Kasl & F. Reichsman. Basel, Switzerland: S. Karger AG, pp. 20–40.
55.
Schwab, J.J. & Traven, N.D. (1979), Psychosomatic illness: Factors related to incidence.Psychosomatics, 20: 307–315.
56.
Sifneos, P. (1967), Clinical observations on some patients suffering from a variety of psychosomatic diseases.Proc. 7th Eur. Conf. Psychosom. Res., 13: 339.
57.
Smith, B.H. & Rosich-Pla, A. (1979), The biochemistry of mental illness.Psychosomatics, 20: 278–283.
58.
Sperling, M. (1967), Transference neurosis in patients with psychosomatic disorders.Psychoanal. Quart., 36: 342–355.
59.
Sperling, M. (1978), Psychosomatic Disorders in Childhood, ed. O. Sperling. New York: Aronson.
60.
Spitz, R.A. (1965), The First Year of Life.New York: International Universities Press.
61.
Syme, S.L., Hyman, M.M., & Enterline, P.E. (1964), Some social and cultural factors associated with the occurrence of coronary heart disease.J. Chron. Dis., 17: 277–289.
62.
Tsuang, M.T. (1975), Genetics of affective disorder. In:The Psychobiology of Depression, ed. J. Mendels. New York: Spectrum, pp. 85–100.
63.
Uexküll, Th.v. (1963), Grundfragen der Psychosomatischen Medizin.Reinbek: Rowohlt.
64.
Weiner, H. et al. (1957), Etiology of duodenal ulcer, I.Psychosom. Med., 19: 1–10.
65.
Weissman, M.M. et al. (1979), The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes.Amer. J. Psychiat., 136: 555–558.
66.
von Weizs$aucker, V. (1949), Psychosomatische medizin.Psyche, 3: 331–341.
67.
Wilson, C.P., ed. (in preparation), Psychodynamic Structure and Treatment of Anorexia Nervosa.New York: Aronson.